Clinical trial
Phase II Randomized Trial of Neoadjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4a (and Selected T4b) Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)
NCT03493425 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Randomized Trial of Neoadjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4a (and Selected T4b) Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)
- Lead sponsor
- ECOG-ACRIN Cancer Research Group
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- March 12, 2019
- Completion date
- March 31, 2029
- Enrollment
- 82 (estimated)
- Sites
- 154
Conditions
As the registry lists them; a condition with its own page is linked.
stage iii sinonasal squamous cell carcinoma ajcc v6 and v7, stage iva sinonasal squamous cell carcinoma ajcc v7